Swapnil Suresh Raskar, PGDCR, MBA

Pune, India
Role: 
Staff
Data Manager
Swapnil Raskar

Swapnil Raskar is a Data Manager for Johns Hopkins Center for Infectious Diseases in India (JH-CIDI) and is based at the Byramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site (BJGMC-JHU-CRS) in Pune, India. for TB Studies.

He has 11 years of experience in clinical data management.

He joined BJGMC-CRS in June 2013. Before joining BJGMC-JHU-CRS, he worked with a couple of CROs and has good experience in all phases of data management, like setting up studies on different database platforms, study conduct, and closeout activities.

Mr. Raskar is trained in HSP-GCP and HIPPA guidelines. He is currently looking after all Data Management activities of several TB studies as below.

  • Regional, Prospective, Observational Research in Tuberculosis (RePORT India) studies at the site including Tuberculosis Research by the Indo-US Medical Partnership (CTRIUMPh) and its several ongoing biomarker sub studies, the phase 1 and 2 Common protocol
  • RICC Pediatric Transcriptomic study
  • Genome Wide Analysis Study (GWAS, Emory University)
  • Dynamics and immune mechanisms of QFT response in close contacts of TB cases
  • Hybrid trial for Alcohol reduction among people with TB and HIV in India (HATHI)
  • A Multicenter Phase II/II Double-Blind, Randomized, Placebo Controlled Study to Evaluate the Efficacy and Safety of VPM1002 in the Prevention of Tuberculosis (TB) Recurrence in Pulmonary TB Patients After Successful TB Treatment in India

He is responsible for all data management activities at the site. He coordinates with study staff to develop protocol source documents and checklists, supervises data management staff. He is responsible for conducting staff training, writing data management standard operating procedures, and maintaining logs for screening & enrollment and follow-up visits, and calculating retention for enrolled participants.

He is also responsible for preparing analyzable datasets as per the requirements shared by study Statisticians or PIs/Researchers across partner universities.

Mr. Raskar also attended NIH/NIAID training under TBDM Cohort study at Durham NC.

Sex Differences in TB Clinical Presentation, Drug Exposure, and Treatment Outcomes in India

Post Date: 
2023-04-01
   |   
Countries: 
Publication: 
CHEST
Background: The role of sex differences in clinical presentation, TB drug pharmacokinetic variables, and treatment outcomes is unclear. Research question: What is the effect of sex on TB disease severity, drug exposure, and treatment outcome? Study design and methods: This study was a prospective...

Diabetes Mellitus and Tuberculosis Treatment Outcomes in Pune, India

Post Date: 
2021-04-01
   |   
Countries: 
   |   
Clinical Sites: 
Publication: 
Open Forum Infectious Diseases
Background Diabetes mellitus (DM) increases the risk of tuberculosis (TB) disease. Knowledge of the impact of DM on TB treatment outcomes is primarily based on retrospective studies. Methods We conducted a prospective cohort study of new pulmonary TB patients with and without DM (TB-DM and TB only...

Respiratory health status is associated with treatment outcomes in pulmonary tuberculosis

Post Date: 
2019-04-19
   |   
Countries: 
Publication: 
The International Journal of Tuberculosis and Lung Disease
BACKGROUND: The association between respiratory impairment and tuberculosis (TB) treatment outcomes is not clear. METHODS: We prospectively evaluated respiratory health status, measured using the Saint George's Respiratory Questionnaire (SGRQ), in a cohort of new adult pulmonary TB cases during and...